Press release
Global Invasive Fungal Infection Market is Predicted to Reach USD 9.06 Billion By 2030 Registering a CAGR of 4.04% | Infinium Global Research
To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/412
Market Insight:
The global invasive fungal infection market, valued at USD 6.61 billion in 2022, is projected to surge to USD 9.06 billion by 2030, marking a stable CAGR of 4.04% during the forecast period 2023-2030. This market sector addresses severe fungal infections that penetrate deep into the body, requiring advanced diagnostics, treatment, and prevention measures to combat life-threatening conditions.
Market Dynamics:
The market growth is primarily fueled by the increasing prevalence of immunocompromised patients, including those with HIV/AIDS, organ transplants, and undergoing chemotherapy, contributing to a higher demand for advanced antifungal therapies. Additionally, advancements in medical technology and diagnostics facilitate early detection, fostering improved patient outcomes. However, the complexity of developing new antifungal therapies poses challenges, balanced by opportunities within the evolving treatment landscape.
Regional Insights:
North America is poised to dominate the market, benefiting from heightened public awareness and proactive health initiatives for invasive fungal diseases. The region's informed populace and robust healthcare infrastructure contribute significantly to market growth. Meanwhile, the Asia Pacific region anticipates substantial growth, driven by higher disease prevalence, government support, and strategic initiatives, particularly evident in India's public-private partnerships to combat fungal infections.
Segmentation:
The report covers disease types such as candidemia, cryptococcal meningitis, invasive aspergillosis, mucormycosis, and more, along with drug types including polyenes and amphotericin b deoxycholate, among others.
Featured Companies:
Profiles of key market players including Basilea Pharmaceutica Ltd., Pfizer Inc., GSK plc., and others offer insights into their contributions and strategies within the invasive fungal infection market.
The Infinium Global Research report on the invasive fungal infection market provides an exhaustive overview, offering stakeholders crucial insights to navigate the evolving dynamics of this critical healthcare sector.
Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/market-reports/customization/412
Table of Content
Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Invasive Fungal Infection Market Highlights
2.2. Invasive Fungal Infection Market Projection
2.3. Invasive Fungal Infection Market Regional Highlights
Chapter 3. Global Invasive Fungal Infection Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter`s Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Disease Type
3.4.2. IGR-Growth Matrix Analysis by Drug Type
3.4.3. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Invasive Fungal Infection Market
Chapter 4. Invasive Fungal Infection Market Macro Indicator Analysis
Chapter 5. Company Profiles and Competitive Landscape
5.1. Competitive Landscape in the Global Invasive Fungal Infection Market
5.2. Companies Profiles
5.2.1. Basilea Pharmaceutica Ltd.
5.2.2. Pfizer Inc.
5.2.3. GSK plc.
5.2.4. Bayer AG
5.2.5. BIOSERGEN
5.2.6. Merck & Co., Inc.
5.2.7. Astellas Pharma Inc.
5.2.8. SCYNEXIS, Inc.
5.2.9. Cidara Therapeutics, Inc.
5.2.10. F2G
Chapter 6. Global Invasive Fungal Infection Market by Disease Type
6.1. Candidemia and Invasive Candidiasis
6.2. Intra-abdominal Candidiasis
6.3. Cryptococcal Meningitis
6.4. Esophageal Candidiasis
6.5. Histoplasmosis Acute Pulmonary
6.6. Invasive Aspergillosis
6.7. Invasive Fungal Rhinosinusitis
6.8. Mucormycosis
6.9. Others
Chapter 7. Global Invasive Fungal Infection Market by Drug Type
7.1. Polyenes
7.2. Amphotericin B Deoxycholate
7.3. Lipid Formulation Amphotericin B
7.4. Others
Chapter 8. Global Invasive Fungal Infection Market by Region 2023-2030
8.1. North America
8.1.1. North America Invasive Fungal Infection Market by Disease Type
8.1.2. North America Invasive Fungal Infection Market by Drug Type
8.1.3. North America Invasive Fungal Infection Market by Country
8.1.3.1. The U.S. Invasive Fungal Infection Market
8.1.3.1.1. The U.S. Invasive Fungal Infection Market by Disease Type
8.1.3.1.2. The U.S. Invasive Fungal Infection Market by Drug Type
8.1.3.2. Canada Invasive Fungal Infection Market
8.1.3.2.1. Canada Invasive Fungal Infection Market by Disease Type
8.1.3.2.2. Canada Invasive Fungal Infection Market by Drug Type
8.1.3.3. Mexico Invasive Fungal Infection Market
8.1.3.3.1. Mexico Invasive Fungal Infection Market by Disease Type
8.1.3.3.2. Mexico Invasive Fungal Infection Market by Drug Type
8.2. Europe
8.2.1. Europe Invasive Fungal Infection Market by Disease Type
8.2.2. Europe Invasive Fungal Infection Market by Drug Type
8.2.3. Europe Invasive Fungal Infection Market by Country
8.2.3.1. Germany Invasive Fungal Infection Market
8.2.3.1.1. Germany Invasive Fungal Infection Market by Disease Type
8.2.3.1.2. Germany Invasive Fungal Infection Market by Drug Type
8.2.3.2. United Kingdom Invasive Fungal Infection Market
8.2.3.2.1. United Kingdom Invasive Fungal Infection Market by Disease Type
8.2.3.2.2. United Kingdom Invasive Fungal Infection Market by Drug Type
8.2.3.3. France Invasive Fungal Infection Market
8.2.3.3.1. France Invasive Fungal Infection Market by Disease Type
8.2.3.3.2. France Invasive Fungal Infection Market by Drug Type
8.2.3.4. Italy Invasive Fungal Infection Market
8.2.3.4.1. Italy Invasive Fungal Infection Market by Disease Type
8.2.3.4.2. Italy Invasive Fungal Infection Market by Drug Type
8.2.3.5. Rest of Europe Invasive Fungal Infection Market
8.2.3.5.1. Rest of Europe Invasive Fungal Infection Market by Disease Type
8.2.3.5.2. Rest of Europe Invasive Fungal Infection Market by Drug Type
8.3. Asia Pacific
8.3.1. Asia Pacific Invasive Fungal Infection Market by Disease Type
8.3.2. Asia Pacific Invasive Fungal Infection Market by Drug Type
8.3.3. Asia Pacific Invasive Fungal Infection Market by Country
8.3.3.1. China Invasive Fungal Infection Market
8.3.3.1.1. China Invasive Fungal Infection Market by Disease Type
8.3.3.1.2. China Invasive Fungal Infection Market by Drug Type
8.3.3.2. Japan Invasive Fungal Infection Market
8.3.3.2.1. Japan Invasive Fungal Infection Market by Disease Type
8.3.3.2.2. Japan Invasive Fungal Infection Market by Drug Type
8.3.3.3. India Invasive Fungal Infection Market
8.3.3.3.1. India Invasive Fungal Infection Market by Disease Type
8.3.3.3.2. India Invasive Fungal Infection Market by Drug Type
8.3.3.4. South Korea Invasive Fungal Infection Market
8.3.3.4.1. South Korea Invasive Fungal Infection Market by Disease Type
8.3.3.4.2. South Korea Invasive Fungal Infection Market by Drug Type
8.3.3.5. Australia Invasive Fungal Infection Market
8.3.3.5.1. Australia Invasive Fungal Infection Market by Disease Type
8.3.3.5.2. Australia Invasive Fungal Infection Market by Drug Type
8.3.3.6. Rest of Asia-Pacific Invasive Fungal Infection Market
8.3.3.6.1. Rest of Asia-Pacific Invasive Fungal Infection Market by Disease Type
8.3.3.6.2. Rest of Asia-Pacific Invasive Fungal Infection Market by Drug Type
8.4. RoW
8.4.1. RoW Invasive Fungal Infection Market by Disease Type
8.4.2. RoW Invasive Fungal Infection Market by Drug Type
8.4.3. RoW Invasive Fungal Infection Market by Sub-region
8.4.3.1. Latin America Invasive Fungal Infection Market
8.4.3.1.1. Latin America Invasive Fungal Infection Market by Disease Type
8.4.3.1.2. Latin America Invasive Fungal Infection Market by Drug Type
8.4.3.2. Middle East Invasive Fungal Infection Market
8.4.3.2.1. Middle East Invasive Fungal Infection Market by Disease Type
8.4.3.2.2. Middle East Invasive Fungal Infection Market by Drug Type
8.4.3.3. Africa Invasive Fungal Infection Market
8.4.3.3.1. Africa Invasive Fungal Infection Market by Disease Type
8.4.3.3.2. Africa Invasive Fungal Infection Market by Drug Type
More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/market-reports/enquiry/412
Reasons to Buy this Report:
=> Comprehensive analysis of global as well as regional markets of invasive fungal infection.
=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.
=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.
=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.
2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027
About Infinium Global Research:
Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.
Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Invasive Fungal Infection Market is Predicted to Reach USD 9.06 Billion By 2030 Registering a CAGR of 4.04% | Infinium Global Research here
News-ID: 3317924 • Views: …
More Releases from Infinium Global Research LLP
Saudi Arabia Healthcare Cybersecurity Market is Expected to Reach USD 1650 Milli …
The Saudi Arabia healthcare cybersecurity market has entered a phase of accelerated growth, driven by the country's ongoing digital transformation and the rapid adoption of advanced healthcare IT platforms. Valued at USD 540 million in 2023, the market is projected to reach USD 1,650 million by 2032, expanding at a CAGR of 15% during 2024-2032. This growth is fueled by the Kingdom's National e-Health Strategy, rising cyberthreats targeting healthcare systems,…
Global Aviation Fuel Market Outlook 2024-2032: Growth from USD 289.34 Billion to …
The aviation fuel market has expanded steadily in recent years, driven by rising global air traffic, economic improvements, and the rapid expansion of commercial and cargo aviation networks. The market was valued at USD 289.34 billion in 2023 and is projected to reach USD 437.34 billion by 2032, reflecting stable expansion supported by increasing aircraft operations, modernization of fleets, and the growing need for reliable fuel logistics. Key growth drivers…
United States Beauty and Wellness Market is Expected to Reach USD 143.27 Million …
The United States beauty and wellness market continues to evolve rapidly, shaped by shifting consumer priorities, rising disposable incomes, digital-first retail strategies, and the strong influence of self-care culture. With a valuation of USD 97 billion in 2023, the market is firmly positioned as one of the world's largest and most dynamic consumer-driven sectors. Increased awareness of holistic wellbeing, demand for clean beauty solutions, and adoption of premium skincare and…
United States Pharmerging Market is Expected to Reach USD 1172.82 Billion in 203 …
The United States pharmerging market has emerged as one of the fastest-growing components of the broader healthcare and pharmaceutical ecosystem, driven by rapid advancements in drug manufacturing, rising healthcare expenditure, and a surge in lifestyle-related diseases. Valued at USD 540 billion in 2023, the market is projected to reach USD 1172.82 billion by 2032, expanding at a CAGR of 9% during 2024-2032. This growth reflects the country's robust pharmaceutical infrastructure…
More Releases for Invasive
Non-Invasive Invasive Laser Lipolysis Machine Market Size, Share and Growth Repo …
On May 9, 2025, Exactitude Consultancy., Ltd. released a research report titled "Non-Invasive Invasive Laser Lipolysis Machine Market". This report covers the global Non-Invasive Invasive Laser Lipolysis Machine market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034…
Aesthetic Medicine Market, By Procedure Type (Invasive Procedures, Non-invasive …
Aesthetic medicine is a type of cosmetic procedure which is used in the treatment to improve scars, wrinkles, liver spots, cellulite, unwanted hair, excess fat and others that will help in augmenting the physical appearance of the patient using minimally invasive and non-invasive procedure.
View Detailed Report: https://www.databridgemarketresearch.com/reports/global-aesthetic-medicine-market
Data Bridge Market Research analyses that the aesthetic medicine market is expected to reach the value of USD 26.68 Billion by the year 2029,…
Minimally Invasive Surgical Instruments Market - Driving Surgical Excellence wit …
Newark, New Castle, USA: The "Minimally Invasive Surgical Instruments Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Minimally Invasive Surgical Instruments Market: https://www.growthplusreports.com/report/minimally-invasive-surgical-instruments-market/7672
This latest report researches the…
Minimally Invasive And Non Invasive Product And Service Market Market Trends Ana …
The research report on the Global Minimally Invasive And Non-Invasive Product And Service Market offers numerous market frameworks, including market size, portion, trends, growth path, value, and factors that affect the current market dynamics throughout the projected period of 2022-2030. Most importantly, along with their market shares, this research also includes the most essential recent strategies used by major companies. The market for minimally invasive and non-invasive goods and services…
Micro-Invasive Glaucoma Implants Micro-Invasive Glaucoma Implants
Global Micro-Invasive Glaucoma Implants Market Definition: Micro-invasive glaucoma implants is performed for the treatment of the open- angle glaucoma and is done through an ab- interno approach. It is very safe and provides faster recovery as compared to the traditional methods. They usually lower the intraocular by increasing the flow or reducing the production of the aqueous humor. Increasing cases of the glaucoma worldwide is the major factor fueling the…
Respiratory Humidification Market for Invasive & Non-Invasive Ventilation | Late …
Researchmoz added Most up-to-date research on "Respiratory Humidification Market (Controller & Consumables) for Invasive & Non-Invasive Ventilation" to its huge collection of research reports.
Respiratory humidification is a method of artificial warming and humidifying of respiratory gas for mechanically ventilated patients. It is a method of artificially conditioning respiratory gas for the patient during therapy. Humidifiers are used in respiratory and acute care (RAC) and for the treatment of sleep apnea.…
